RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jesus A. Angulo to Dopamine Antagonists

This is a "connection" page, showing publications Jesus A. Angulo has written about Dopamine Antagonists.
Connection Strength

0.390
  1. Noailles PA, Villegas M, Ledoux M, Lucas LR, McEwen BS, Angulo JA. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain. Neurosci Lett. 1996 Jan 05; 202(3):165-68.
    View in: PubMed
    Score: 0.134
  2. Tulloch I, Ghazaryan N, Mexhitaj I, Ordonez D, Angulo JA. Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice. Brain Res. 2011 Jul 05; 1399:33-9.
    View in: PubMed
    Score: 0.097
  3. Wang J, Angulo JA. Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice. Synapse. 2011 Apr; 65(4):300-8.
    View in: PubMed
    Score: 0.093
  4. Xu W, Zhu JP, Angulo JA. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse. 2005 Nov; 58(2):110-21.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support